Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7365066 Pyrazolopyridine derivatives as pharmaceutical agents

Patent 7365066 was granted and assigned to Eli Lilly and Company on April, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Eli Lilly

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73650660

Patent Inventor Names

Jeremy Schulenburg York0

Jonathan Michael Yingling0

Rosanne Bonjouklian0

Junkai Liao0

William Thomas McMillen0

Brandon Lee Parkhurst0

Douglas Wade Beight0

Jason Scott Sawyer0

Date of Patent

April 29, 2008

Patent Application Number

105245770

Date Filed

September 16, 2003

Patent Primary Examiner

‌

Margaret D. Seaman

Patent abstract

Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7365066 Pyrazolopyridine derivatives as pharmaceutical agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API